Discovery of 6alpha-ethyl-23(S)-methylcholic acid (S-EMCA, INT-777) as a potent and selective agonist for the TGR5 receptor, a novel target for diabesity.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples